Document Detail


Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
MedLine Citation:
PMID:  22114905     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective: FT (FlexTouch 1 ) is a new prefilled insulin pen with no push-button extension at any set dose and a low activation force that is designed to improve ease of use and insulin administration. This paper reports the results of two usability studies assessing perceptions of FT compared with KP (KwikPen (2) ) and SS (SoloStar (3) ) among healthcare professionals (HCPs; both physicians and nurses) and people with diabetes (both insulin pen-experienced and insulin pen-naïve). * FlexTouch is a registered trade name of Novo Nordisk A/S, Bagsvaerd, Denmark † KwikPen is a registered trade name of Eli Lilly & Co., Indianapolis, IN, USA ‡ SoloStar is a registered trade name of Sanofi, Paris, France Research design and methods: Participants were randomly assigned to start with FT or KP in one study and FT or SS in the other. Participants performed injections at different doses (20, 40 and 60 International Units [IU] in the FT vs. KP study or 20, 40 and 80 IU in the FT vs. SS study) into a foam cushion before answering questions on ease of use, teaching and learning, confidence and preference. Results: A total of 59 people with diabetes and 61 HCPs took part in the FT vs. SS study, and 79 people with diabetes and 81 HCPs took part in the FT vs. KP study. Considerably more patients and HCPs rated FT as very/fairly easy to inject with than KP or SS, particularly at the maximum dose (≥80% vs. ≤38% and ≤23%, respectively), and more were very/rather confident in the ability to manage daily insulin injections with FT than KP or SS. Overall, FT was rated significantly higher for ease of teaching and learning to use than KP or SS (all p < 0.001 vs. FT), and was preferred for teaching and learning compared with KP or SS (≥39% vs. ≤4% and ≤6%, respectively). More patients and HCPs would recommend FT (≥95%) than KP (≤72%) or SS (≤71%). The same pattern was generally seen across physicians, nurses, insulin pen-experienced and pen-naïve participants. Conclusions: The findings suggest that devices such as FT are easy to use and can be prescribed with relatively few training needs, which may improve ease of insulin initiation, increase pen use, and ultimately improve treatment adherence. A limitation of the usability questionnaire used in this study is that it did not assess the factors that influence preference. Further analyses could be conducted to determine the factors that appeal to different users.
Authors:
Daniel A Nadeau; Carlos Campos; Marcus Niemeyer; Timothy Bailey
Related Documents :
6689885 - Dissociation of glucose and potassium arterial-venous differences across the forearm by...
8522055 - Improvement of insulin action in diabetic transgenic mice selectively overexpressing gl...
1506395 - Contraction-activated glucose uptake is normal in insulin-resistant muscle of the obese...
11052965 - Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic sub...
11854095 - Susceptibility gene discovery for common metabolic and endocrine traits.
8871675 - High density insulin receptor-positive t lymphocytes from nonobese diabetic mice transf...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-25
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
York Hospital , 127 Long Sands Road 6B, York, ME 03909 , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, c...
Next Document:  Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in mo...